Stock Alert: Guardant Health Up 7%

Shares of Guardant Health, Inc. (GH), a precision oncology company, that provides blood tests, data sets, and analytics, climbed $5.71 or 7.53% on Wednesday after reporting narrower than estimated loss in the fourth quarter.

Guardant Health reported loss of $25.2 million or $0.27 in the fourth quarter compared with $25.1 million or $0.30 per share loss for the corresponding period last year. 7 analysts on average polled by Thomson Reuters were expecting loss of $0.31 per share.

Revenue increased 91% year-on-year to $62.9 million, helped mainly by 104% increase in precision oncology revenue on higher testing volume.

For the full-year, the company expects revenue to be in the range of $275.0 million to $285.0 million

Looking forward, Derek Bertocci, Chief Financial Officer said, "In 2020, we expect contributions from our biopharma business to be lighter in the first quarter. ... we expect revenue to benefit - to begin to benefit from the expanded Medicare LCD in the second quarter of 2020 with more full benefit in the third quarter and beyond."

The stock closed Wednesday's trade at $81.50 and has traded in the range of $54- $112.22. From October last year, the shares have been upticking with nearly 40% growth in almost 5 months.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Editors Pick
Cove Appliance Inc. is recalling about 42,000 units of built-in dishwashers citing fire risk, the U.S. Consumer Product Safety Commission said. The recall involves Cove Appliance 24-inch built-in residential dishwashers model numbers DW2450 and DW2450WS. The recalled dishwashers have serial numbers 20000100 through 20044445. Mallinckrodt plc announced Wednesday that the U.S. Food and Drug Administration or FDA has approved StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen - dsat) for the treatment of adult patients with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated. Worldwide 5G mobile subscriptions are estimated to exceed 580 million by the end of 2021, according to the Ericsson Mobility Report. With subscriptions increasing at a rate of about a million per day, 5G remains on track to become the fastest adopted mobile generation in history. The growth in subscriptions is being lead by China, North America and the Gulf Cooperation Council markets.
Follow RTT